QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
QQQ   310.34 (+1.43%)
AAPL   159.28 (+1.19%)
MSFT   273.78 (+0.57%)
META   202.16 (+2.20%)
GOOGL   104.92 (+3.66%)
AMZN   100.61 (+2.97%)
TSLA   197.58 (+7.82%)
NVDA   261.99 (+1.15%)
NIO   9.27 (+5.94%)
BABA   83.70 (+3.33%)
AMD   95.93 (-0.91%)
T   18.54 (+0.27%)
F   11.72 (+4.83%)
MU   58.63 (+1.72%)
CGC   1.97 (+5.91%)
GE   92.18 (+2.51%)
DIS   96.54 (+2.46%)
AMC   4.41 (+3.28%)
PFE   40.66 (-0.37%)
PYPL   76.72 (+4.79%)
NFLX   305.79 (+0.22%)
NASDAQ:MYGN

Myriad Genetics - MYGN Earnings Date, Estimates & Call Transcripts

$23.39
-0.36 (-1.52%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$23.17
▼
$23.96
50-Day Range
$17.32
▼
$23.75
52-Week Range
$13.92
▼
$28.18
Volume
402,302 shs
Average Volume
644,859 shs
Market Capitalization
$1.90 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.20
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

MYGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MYGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Myriad Genetics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20231($0.09)($0.09)($0.09) - $0.20 - - $0.18
Q2 20231($0.08)($0.08)($0.08) 
Q3 20231($0.08)($0.08)($0.08) 
Q4 20231($0.03)($0.03)($0.03) 
FY 20234($0.28)($0.28) ($0.28)

MYGN Earnings Date and Information

Myriad Genetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 4th, 2023 based off prior year's report dates.

Myriad Genetics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/4/2023
(Estimated)		        
11/1/2022Q3 2022($0.15)($0.27)($0.12)($0.11)$172.12 million$156.40 million
8/4/2022Q2 2022($0.09)($0.06)+$0.03$0.06$170.05 million$179.30 million    
5/5/2022Q1 2022($0.15)($0.14)+$0.01($0.02)$156.09 million$164.90 million      
2/24/2022Q4 2021($0.15)($0.11)+$0.04($0.12)$162.21 million$160.80 million    
11/2/20219/30/2021($0.02)($0.02)($0.54)$164.35 million$167.30 million    
8/3/20216/30/2021($0.09)$0.12+$0.21$0.12$163.09 million$189.40 million  
5/2/20213/31/2021($0.15)($0.06)+$0.09$0.20$155.36 million$173.10 million  
2/22/2021Q1 21($0.12)($0.12)$0.21$148.11 million$154.60 million  
11/9/20209/30/2020($0.30)($0.15)+$0.15($0.18)$134.59 million$145.20 million  
8/13/20206/30/2020($0.47)($0.31)+$0.16$0.08$95.44 million$93.20 million  
5/5/20203/31/2020$0.02($0.08)($0.10)$1.23$167.38 million$164.00 million  
2/6/2020Q2 2020$0.22$0.23+$0.01$0.41$209.61 million$195.10 million  
11/4/2019Q1$0.26$0.08($0.18)$0.22$202.34 million$186.30 million  
8/13/2019Q4 19$0.40$0.41+$0.01$0.66$221.64 million$215.40 million  
5/7/20193/31/2019$0.38$0.34($0.04)$0.59$217.76 million$216.60 million
2/5/201912/31/2018$0.34$0.38+$0.04$0.57$217.69 million$216.80 million  
11/6/20189/30/2018$0.30$0.43+$0.13$0.71$203.20 million$202.30 million  
8/21/20186/30/2018$0.33$0.38+$0.05$0.58$195.93 million$200.90 million
5/8/2018Q3$0.27$0.31+$0.04$0.46$188.22 million$193.50 million
2/6/2018Q2 2018$0.2360$0.31+$0.0740$0.17$188.72 million$194.00 million  
11/7/2017Q1 2018$0.21$0.26+$0.05($0.63)$183.52 million$190.20 million
8/8/2017Q4 17$0.26$0.30+$0.04$0.41$193.71 million$200.50 million  
5/2/2017Q3 2017$0.2380$0.27+$0.0320$0.48$188.89 million$196.90 million  
2/7/2017Q2 2017$0.24$0.26+$0.02$0.43$189.72 million$196.50 million  
11/1/2016Q117$0.26$0.23($0.03)$0.48$172.31 million$177.50 million
8/9/2016Q416$0.38$0.36($0.02)$0.40$187.95 million$186.50 million
5/3/2016Q316$0.38$0.41+$0.03$0.38$185.08 million$190.50 million
2/2/2016Q216$0.41$0.45+$0.04$0.49$189.99 million$193.30 million
11/3/2015Q116$0.35$0.41+$0.06$0.45$177.89 million$183.50 million
8/11/2015Q415$0.42$0.41($0.01)$0.56$187.81 million$189.90 million  
5/5/2015Q315$0.39$0.40+$0.01$0.51$183.30 million$180.00 million  
2/3/2015Q215$0.35$0.40+$0.05$0.48$183.41 million$184.40 million  
11/4/2014Q115$0.33$0.25($0.08)$0.29$175.00 million$168.84 million  
8/12/2014Q414$0.46$0.48+$0.02$0.53$187.68 million$188.80 million  
5/6/2014Q314$0.45$0.60+$0.15$0.72$175.23 million$182.92 million  
2/4/2014Q2 2014$0.47$0.66+$0.19$0.66$176.02 million$204.06 million  
11/5/2013Q1 2014$0.46$0.68+$0.22$0.68$167.64 million$202.50 million  
8/13/2013Q4 2013$0.44$0.53+$0.09$0.53$159.87 million$174.10 million  
5/7/2013Q3 2013$0.39$0.46+$0.07$0.46$148.25 million$156.40 million
2/5/2013Q2 2013$0.38$0.42+$0.04$143.71 million$140.70 million  
11/5/2012Q113$0.32$0.36+$0.04$129.84 million$133.40 million
8/14/2012$0.34$0.34  
5/1/2012$0.32$0.34+$0.02  
1/31/2012$0.31$0.33+$0.02
11/1/2011$0.27$0.29+$0.02
8/9/2011$0.29$0.30+$0.01  
5/3/2011$0.25$0.31+$0.06
1/27/2011$0.26$0.26
11/2/2010Q1 2011$0.23$0.24+$0.01$0.24
8/10/2010Q4 2010$0.33$0.39+$0.06$0.24
5/4/2010Q3 2010$0.38$0.33($0.05)$0.33
2/2/2010Q2 2010$0.34$0.36+$0.02$0.36
11/3/2009Q1 2010$0.32$0.31($0.01)$0.31
8/25/2009Q4 2009$0.23$0.37+$0.14$0.50
5/4/2009Q3 2009$0.23$0.25+$0.02$0.25
2/3/2009Q2 2009$0.17$0.22+$0.05$0.22
11/4/2008Q1 2009$0.07$0.15+$0.08$0.15
8/19/2008Q4 2008($0.12)$0.70+$0.82$0.70
5/6/2008Q3 2008($0.05)($0.05)($0.05)
2/5/2008Q2 2008($0.08)($0.06)+$0.02($0.06)












Myriad Genetics Earnings - Frequently Asked Questions

When is Myriad Genetics's earnings date?

Myriad Genetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 4th, 2023 based off last year's report dates. Learn more on MYGN's earnings history.

How much revenue does Myriad Genetics generate each year?

Myriad Genetics (NASDAQ:MYGN) has a recorded annual revenue of $678.40 million.

How much profit does Myriad Genetics generate each year?

Myriad Genetics (NASDAQ:MYGN) has a recorded net income of -$112 million. MYGN has generated -$1.39 earnings per share over the last four quarters.

What is Myriad Genetics's EPS forecast for next year?

Myriad Genetics's earnings are expected to grow from ($0.80) per share to ($0.36) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:MYGN) was last updated on 3/21/2023 by MarketBeat.com Staff